New Data Presented at AAIC 2024 Demonstrates High Accuracy of Blood Tests Incorporating ALZpath Proprietary pTau217 Antibody for Alzheimer’s Disease Diagnosis

Study Showed High Accuracy in Determining Amyloid Burden Across All Stages of Alzheimer’s Disease Progression, Supporting Early Detection, Treatment, Interventions and Tracking ALZpath pTau217 Antibody Has Now Been Utilized in Over 40 Cohort Studies with 50,000 Samples CARLSBAD, Calif.,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.